Changes in CD44 expression during carcinogenesis of the mouse colon

Experimental and Molecular Pathology

Volumn 64, Issue 2, 1997, Pages 114-125

  Rudzki, Zbigniew ^a   LeDuy, Lam ^a   Jothy, Serge ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; COLON CARCINOGENESIS; COLON CARCINOMA; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; SOUTHERN BLOTTING;

ANIMALIA; MURINAE;

EID: 0031126517     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1006/exmp.1997.2214     Document Type: Article

References (30)

1. Bourguignon L. Y., Walker G., Suchard S. J., Balazovich K. A lymphoma plasma membrane-associated protein with ankyrin-like properties. J. Cell Biol. 102:1986;2115-2124.
2. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
3. Finke L. H., Terpe H. J., Zorb C., Haensch W., Schlag P. M. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet. 345:1995;583.
4. Gorham H., Sugino T., Bolodeoku J., Yoshida K., Goodison S., Tarin D. Distribution of CD44 messenger RNA in archival paraffin wax embedded tumours and normal tissues viewed by in situ hybridisation. J. Clin. Pathol.: Mol. Pathol. 49:1996a;M147-M150.
5. Gorham H., Sugino T., Woodman A. C., Tarin D. Cellular distribution of CD44 gene transcripts in colorectal carcinomas and in normal colonic mucosa. J. Clin. Pathol. 49:1996b;482-488.
6. Gotley D. C., Fawcett J., Walsh M. D., Reeder J. A., Simmons D. L., Antalis T. M. Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer. Br. J. Cancer. 74:1996;342-351.
7. Günthert U., Hofmann M., Rudy W., Reber S., Zoller M., Haussmann I., Matzku S., Wenzel A., Ponta H., Herrlich P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 65:1991;13-24.
8. Haase P., Cowen D. M., Knowles J. C., Cooper E. H. Evaluation of dimethylhydrazine induced tumours in mice as a model system for colorectal cancer. Br. J. Cancer. 28:1973;530-543.
9. Heider K. H., Hofmann M., Hors E., van den Berg F., Ponta H., Herrlich P., Pals S. T. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. J. Cell Biol. 120:1993;227-233.
10. Ichikawa W. Positive relationship between expression of CD44 and hepatic metastases in colorectal cancer. Pathobiology. 62:1994;172-179.
11. Imazeki F., Yokosuka O., Yamaguchi T., Ohto M., Isono K., Omata M. Expression of variant CD44-messenger RNA in colorectal adenocarcinomas and adenomatous polyps in humans. Gastroenterology. 110:1996;362-368.
12. Jackson P. A., Green M. A., Pouli A., Hubbard R., Marks C. G., Cook M. G. Relation between stage, grade, proliferation, and expression of p53 and CD44 in adenomas and carcinomas of the colorectum. J. Clin. Pathol. 48:1995;1098-1101.
13. Kim H., Yang X. L., Rosada C., Hamilton S. R., August J. T. CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation. Arch. Biochem. Biophys. 310:1994;504-507.
14. Koopman G., Heider K. H., Horst E., Adolf G. R., van den Berg F., Ponta H., Herrlich P., Pals S. T. Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J. Exp. Med. 177:1993;897-904.
15. Mackay C. R., Terpe H. J., Stauder R., Marston W. L., Stark H., Günthert U. Expression and modulation of CD44 variant isoforms in humans. J. Cell Biol. 124:1993;71-82.
16. Matsumura Y., Tarin D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet. 340:1992;1053-1058.
17. Miyake K., Medina K. L., Hayashi S., Ono S., Hamaoka T., Kincade P. W. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J. Exp. Med. 171:1990;477-488.
18. Moen C. J., Groot P. C., Hart A. A., Snoek M., Demant P. Fine mapping of colon tumor susceptibility (Scc) genes in the mouse, different from the genes known to be somatically mutated in colon cancer. Proc. Natl. Acad. Sci. USA. 93:1996;1082-1086.
19. Mulder J. W., Wielenga V. J., Polak M. M., van den Berg F. M., Adolf G. R., Herrlich P., Pals S. T., Offerhaus G. J. Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis. Gut. 36:1995;76-80.
20. Rudzki Z., Jothy S. CD44 and the adhesion of neoplastic cells. J. Clin. Pathol.: Mol. Pathol. 50:1977;57-71.
21. Screaton G. R., Bell M. V., Bell J. I., Jackson D. G. The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor: Comparison of all 10 variable exons between mouse, human, and rat. J. Biol. Chem. 268:1993;12235-12238.
22. Screaton G. R., Bell M. V., Jackson D. G., Cornelis F. B., Gerth U., Bell J. I. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. USA. 89:1992;12160-12164.
23. Sugino T., Gorham H., Yoshida K., Bolodeoku J., Nargund V., Cranston D., Goodison S., Tarin D. Progressive loss of CD44 gene expression in invasive bladder cancer. Am. J. Pathol. 149:1996;873-882.
24. Tölg C., Hofmann M., Herrlich P., Ponta H. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res. 21:1993;1225-1229.
25. Toth B., Malick L., Shimizu H. Production of intestinal and other tumors by 1,2-dimethylhydrazine dihydrochloride in mice. I. A light and transmission electron microscopic study of colonic neoplasms. Am. J. Pathol. 84:1976;69-86.
26. Tsukita S., Oishi K., Sato N., Sagara J., Kawai A., Tsukita S. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J. Cell Biol. 126:1994;391-401.
27. Wielenga V. J., Heider K. H., Offerhaus G. J., Adolf G. R., van den Berg F. M., Ponta H., Herrlich P., Pals S. T. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res. 53:1993;4754-4756.
28. Woodman A. C., Sugiyama M., Yoshida K., Sugino T., Borgya A., Goodison S., Matsumura Y., Tarin D. Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms. Am. J. Pathol. 149:1996;1519-1530.
29. Yang B., Yang B. L., Savani R. C., Turley E. A. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J. 13:1994;286-296.
30. Yoshida K., Bolodeoku J., Sugino T., Goodison S., Matsumura Y., Warren B. F., Toge T., Tahara E., Tarin D. Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors. Cancer Res. 55:1995;4273-4277.